Market Overview:
The global polycystic ovarian syndrome treatment market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Polycystic ovarian syndrome (PCOS) refers to a hormonal disorder that leads to the abnormal and excessive production of male hormones in females. It is characterized by hyperandrogenism, ovulatory dysfunction and the development of polycystic ovaries. The disorder can also cause acne, darkening of the skin, weight gain and missed or irregular menstrual cycles, leading to infertility and development of cysts or small fluid-filled sacs in the ovaries. Some of the commonly used treatment methods for regulating and managing PCOS include oral contraceptives, antiandrogens, insulin-sensitizing agents, antidepressants and anti-obesity medicines, along with various surgical procedures, such as ovarian wedge resection and laparoscopic ovarian drilling.
The increasing prevalence of PCOS across the globe represents one of the key factors driving the growth of the market. Furthermore, rising health consciousness and increasing awareness regarding the available treatment alternatives for PCOS are also driving the market growth. PCOS often leads to hirsutism, obesity, diabetes, infertility and other chronic ailments, which has enhanced the requirement for effective treatment alternatives to manage the disease efficiently. In line with this, widespread adoption of laparoscopic ovarian drilling, which involves the surgical triggering of ovulation in women, as an effective treatment for PCOS, is also contributing to the market growth. Additionally, various technological advancements, such as the development of improved pharmacological agents, including androgen suppressors and peripheral androgen blockers, are also favoring the market growth. Other factors, including rising healthcare expenditure of the individuals, along with extensive research and development (R&D) activities, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global polycystic ovarian syndrome treatment market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, drug class, surgery type and distribution channel.
Breakup by Drug Class:
- Oral Contraceptives
- Antiandrogens
- Insulin-sensitizing Agent
- Antidepressant
- Anti-obesity
- Others
Breakup by Surgery Type:
- Ovarian Wedge Resection
- Laparoscopic Ovarian Drilling
Breakup by Distribution Channel:
- Hospitals and Clinics
- Retail Pharmacies
- Online Stores
- Others
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Company, Ferring B.V., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Teva Pharmaceutical Industries Ltd.
Report Coverages:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2020 |
| Historical Period |
2015-2020 |
| Forecast Period |
2021-2026 |
| Units |
US$ Billion |
| Segment Coverage |
Drug Class, Surgery Type, Distribution Channel, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Abbott Laboratories, AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Company, Ferring B.V., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Teva Pharmaceutical Industries Ltd |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global polycystic ovarian syndrome treatment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global polycystic ovarian syndrome treatment market?
- What are the key regional markets?
- What is the breakup of the market based on the drug class?
- What is the breakup of the market based on the surgery type?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global polycystic ovarian syndrome treatment market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Polycystic Ovarian Syndrome Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Class
6.1 Oral Contraceptives
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Antiandrogens
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Insulin-sensitizing Agent
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Antidepressant
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Anti-obesity
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Surgery Type
7.1 Ovarian Wedge Resection
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Laparoscopic Ovarian Drilling
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AstraZeneca Plc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bayer AG
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bristol Myers Squibb Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Ferring B.V.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Merck KGaA
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Novartis AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sanofi S.A.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Teva Pharmaceutical Industries Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: Polycystic Ovarian Syndrome Treatment Market: Major Drivers and Challenges
Figure 2: Global: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Polycystic Ovarian Syndrome Treatment Market: Breakup by Drug Class (in %), 2020
Figure 5: Global: Polycystic Ovarian Syndrome Treatment Market: Breakup by Surgery Type (in %), 2020
Figure 6: Global: Polycystic Ovarian Syndrome Treatment Market: Breakup by Distribution Channel (in %), 2020
Figure 7: Global: Polycystic Ovarian Syndrome Treatment Market: Breakup by Region (in %), 2020
Figure 8: Global: Polycystic Ovarian Syndrome Treatment (Oral Contraceptives) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Polycystic Ovarian Syndrome Treatment (Oral Contraceptives) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Polycystic Ovarian Syndrome Treatment (Antiandrogens) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Polycystic Ovarian Syndrome Treatment (Antiandrogens) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Polycystic Ovarian Syndrome Treatment (Insulin-sensitizing Agent) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Polycystic Ovarian Syndrome Treatment (Insulin-sensitizing Agent) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Polycystic Ovarian Syndrome Treatment (Antidepressant) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Polycystic Ovarian Syndrome Treatment (Antidepressant) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Polycystic Ovarian Syndrome Treatment (Anti-obesity) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Polycystic Ovarian Syndrome Treatment (Anti-obesity) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Polycystic Ovarian Syndrome Treatment (Other Drug Classes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Polycystic Ovarian Syndrome Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Polycystic Ovarian Syndrome Treatment (Ovarian Wedge Resection) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Polycystic Ovarian Syndrome Treatment (Ovarian Wedge Resection) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Polycystic Ovarian Syndrome Treatment (Laparoscopic Ovarian Drilling) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Polycystic Ovarian Syndrome Treatment (Laparoscopic Ovarian Drilling) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Polycystic Ovarian Syndrome Treatment (Hospitals and Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Polycystic Ovarian Syndrome Treatment (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Polycystic Ovarian Syndrome Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Polycystic Ovarian Syndrome Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Polycystic Ovarian Syndrome Treatment (Online Stores) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Polycystic Ovarian Syndrome Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Polycystic Ovarian Syndrome Treatment (Other Distribution Channels) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Polycystic Ovarian Syndrome Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: North America: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: North America: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: United States: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: United States: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Canada: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Canada: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Asia Pacific: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Asia Pacific: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: China: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: China: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Japan: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Japan: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: India: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: India: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: South Korea: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: South Korea: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Australia: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Australia: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Indonesia: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Indonesia: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Others: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Others: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Europe: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Europe: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Germany: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Germany: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: France: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: France: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: United Kingdom: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: United Kingdom: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Italy: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Italy: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Spain: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Spain: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Russia: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Russia: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Others: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Others: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Latin America: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Latin America: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Brazil: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Brazil: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Mexico: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Mexico: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Others: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Others: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Middle East and Africa: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Middle East and Africa: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Global: Polycystic Ovarian Syndrome Treatment Industry: SWOT Analysis
Figure 81: Global: Polycystic Ovarian Syndrome Treatment Industry: Value Chain Analysis
Figure 82: Global: Polycystic Ovarian Syndrome Treatment Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Polycystic Ovarian Syndrome Treatment Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Polycystic Ovarian Syndrome Treatment Market Forecast: Breakup by Drug Class (in Million US$), 2021-2026
Table 3: Global: Polycystic Ovarian Syndrome Treatment Market Forecast: Breakup by Surgery Type (in Million US$), 2021-2026
Table 4: Global: Polycystic Ovarian Syndrome Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 5: Global: Polycystic Ovarian Syndrome Treatment Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Polycystic Ovarian Syndrome Treatment Market: Competitive Structure
Table 7: Global: Polycystic Ovarian Syndrome Treatment Market: Key Players